About this Journal Submit a Manuscript Table of Contents
ISRN Rheumatology
Volume 2013 (2013), Article ID 357904, 9 pages
http://dx.doi.org/10.1155/2013/357904
Review Article

Oral Janus Kinase Inhibitor for the Treatment of Rheumatoid Arthritis: Tofacitinib

1Internal Medicine, SEGi University, No. 9 Jalan Teknologi, Taman Sains Selangor, Kota Damansara, PJU 5, 47810 Petaling Jaya, Selangor, Malaysia
2Community Medicine, Melaka Manipal Medical College, Jalan Batu Hampar, Bukit Baru, Malacca 75150, Malaysia
3Ophthalmology, Melaka Manipal Medical College, Jalan Batu Hampar, Bukit Baru, Malacca 75150, Malaysia
4Diagnostic Radiology, Defense Service General Hospital, Naypyitaw, Myanmar

Received 30 May 2013; Accepted 29 June 2013

Academic Editors: O. Sander and P. Voulgari

Copyright © 2013 Han Ni et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Han Ni, Soe Moe, Kay Thi Myint, and Aung Htet, “Oral Janus Kinase Inhibitor for the Treatment of Rheumatoid Arthritis: Tofacitinib,” ISRN Rheumatology, vol. 2013, Article ID 357904, 9 pages, 2013. doi:10.1155/2013/357904